Utility of Minimum Apparent Diffusion Coefficient Ratios in Alberta Stroke Program Early CT Score Regions for Deciding on Stroke Therapy

Background and Purpose: Therapeutic indications for recombinant tissue plasminogen activator therapy and endovascular therapy need to be assessed for patients with hyperacute ischemic stroke. We investigated the relationship between the minimum apparent diffusion coefficient ratios in each Alberta Stroke Program Early CT Score region and reversible lesion in patients with hyperacute ischemic stroke receiving recombinant tissue plasminogen activator therapy and/or treated with endovascular therapy.

Source: Journal of Stroke and Cerebrovascular Diseases - February 22, 2019 Category: Neurology Authors: Yuta Maetani, Masahiro Nakamori, Eiji Imamura, Yosuke Ishii, Hiroshi Aihara, Yoshio Suyama, Shinichi Wakabayashi, Hirofumi Maruyama Source Type: research